In:
Journal of the International Child Neurology Association, The International Child Neurology Association (ICNA), ( 2019-07-25)
Abstract:
Emerging genetic therapies for rare disorders at high cost, cannot realistically address the global burden of disease. Stakeholders must develop new pathways to ensure safe, fair and sustainable provision of such therapies.
Type of Medium:
Online Resource
ISSN:
2410-6410
DOI:
10.17724/jicna.2019.172
Language:
Unknown
Publisher:
The International Child Neurology Association (ICNA)
Publication Date:
2019
Permalink